Boston University vs. Emory: Which offers better undergraduate medical research opportunities?

Emory offers a modest edge for an undergraduate whose top priority is direct access to biomedical and clinical research. Its undergraduate campus is closely integrated with Emory School of Medicine, Emory Healthcare, Winship Cancer Institute, and major public-health research activity. The nearby Centers for Disease Control and Prevention also creates an unusually strong environment for students interested in infectious disease, epidemiology, global health, and translational medicine.

Programs such as the Emory Undergraduate Research Program and the Summer Undergraduate Research Experience can help students find structured entry points, although joining a lab still depends on initiative, timing, and faculty capacity.

Boston University remains an excellent option, particularly for clinically oriented research. BU students can pursue projects through the Chobanian & Avedisian School of Medicine and Boston Medical Center, which are adjacent to the undergraduate campus, and the university supports undergraduates through its Undergraduate Research Opportunities Program. Boston also provides access to a dense medical and biotech environment, so a proactive student can find work beyond BU through hospitals, research institutes, and community-health organizations.

The practical distinction is that Emory has a more unified academic medical center and public-health network, while BU pairs a strong home institution with the broader Boston research landscape. For someone seeking a relatively streamlined path into faculty biomedical or clinical labs, Emory has the advantage. At either school, the students who secure the strongest positions typically begin contacting labs early, after gaining enough coursework or technical preparation to explain a specific research interest.